Literature DB >> 2555564

Priming for rotavirus neutralizing antibodies by a VP4 protein-derived synthetic peptide.

C F Arias1, G Garcia, S Lopez.   

Abstract

In the rotavirus SA11 surface protein VP4, the trypsin cleavage sites associated with the enhancement of infectivity are flanked by two amino acid regions that are highly conserved among different rotaviruses. We have tested the ability of synthetic peptides that mimic these two regions to induce and prime for a rotavirus neutralizing antibody response in mice. After the peptide immunization schedule, both peptides induced peptide antibodies, but neither was able to induce virus antibodies, as measured by an enzyme-linked immunosorbent assay or a neutralization assay. However, when the peptide-inoculated mice were subsequently injected with intact SA11 virus, a rapid and high neutralizing antibody response was observed in mice that had previously received the peptide comprising amino acids 220 to 233 of the VP4 protein. This neutralizing activity was serotype specific; however, this peptide was also able to efficiently prime the immune system of mice for a neutralizing antibody response to the heterotypic rotavirus ST3 when the ST3 virus was used for the secondary inoculation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555564      PMCID: PMC251206          DOI: 10.1128/JVI.63.12.5393-5398.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Comparison of the genomes of simian, bovine, and human rotaviruses by gel electrophoresis and detection of genomic variation among bovine isolates.

Authors:  S M Rodger; I H Holmes
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

2.  Preparation and characterization of antisera to electrophoretically purified SA11 virus polypeptides.

Authors:  J W Bastardo; J L McKimm-Breschkin; S Sonza; L D Mercer; I H Holmes
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

3.  Proteolytic enhancement of rotavirus infectivity: molecular mechanisms.

Authors:  M K Estes; D Y Graham; B B Mason
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

4.  Structural polypeptides of simian rotavirus SA11 and the effect of trypsin.

Authors:  R T Espejo; S López; C Arias
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

5.  Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation.

Authors:  A R Kalica; J Flores; H B Greenberg
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

6.  Purification of an outer capsid glycoprotein of neonatal calf diarrhea virus and preparation of its antisera.

Authors:  S Matsuno; S Inouye
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Gene protein products of SA11 simian rotavirus genome.

Authors:  C F Arias; S López; R T Espejo
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

8.  Biochemical mapping of the simian rotavirus SA11 genome.

Authors:  B B Mason; D Y Graham; M K Estes
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  A synthetic peptide corresponding to the cleavage region of VP3 from rotavirus SA11 induces neutralizing antibodies.

Authors:  H J Streckert; H Brüssow; H Werchau
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera.

Authors:  S Matsuno; S Inouye; R Kono
Journal:  J Clin Microbiol       Date:  1977-01       Impact factor: 5.948

View more
  4 in total

1.  Operational overlapping of cross-reactive and serotype-specific neutralization epitopes on VP7 of human rotavirus serotype 3.

Authors:  N Kobayashi; K Taniguchi; S Urasawa
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children.

Authors:  H Brüssow; P A Offit; J Sidoti
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Trypsin activation pathway of rotavirus infectivity.

Authors:  C F Arias; P Romero; V Alvarez; S López
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

4.  The amino-terminal half of rotavirus SA114fM VP4 protein contains a hemagglutination domain and primes for neutralizing antibodies to the virus.

Authors:  M Lizano; S López; C F Arias
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.